Francisco Partners Converts 7.5M Class B Shares, Sells $9.7M in GoodRx Stock
GDRX sits 97% above its 52-week low of $1.77.
Summary
Francisco Partners converted 7.5M Class B shares to Class A, distributed 4.74M shares to partners, and sold 2.74M shares for $9.7M — a larger sale than previously disclosed, but the firm still holds 32.9% of the class.
Key Events · Ownership and Investor Activity · GDRX
-
Class B Conversion and Distribution
On August 20, 2026, Francisco Partners IV and IV-A converted 7,500,000 Class B shares to Class A shares and distributed 4,739,005 Class A shares pro rata to their general partner and limited partners for no consideration.
-
$9.7M Share Sale
The remaining 2,743,043 Class A shares from the conversion were sold for aggregate proceeds of $9,678,731.50, with proceeds distributed to partners — a larger sale than the $5.5M disclosed in the concurrent Form 4.
-
Substantial Remaining Stake
Post-transaction, Francisco Partners entities collectively hold 52,578,184 Class B shares (32.9% of the class), contradicting the 'near-complete exit' characterization in the concurrent Form 4 alert.
-
Potential Future Selling Pressure
The in-kind distribution of 4.74 million Class A shares to limited partners creates potential future selling pressure as those partners may liquidate their newly received shares.
Analysis · GDRX · Technology
A major restructuring of Francisco Partners' GoodRx position took place on August 20, 2026, involving the conversion of 7.5 million Class B shares to Class A, a distribution of 4.74 million shares to limited partners, and a sale of 2.74 million shares for $9.7 million. This sale is materially larger than the $5.5 million disclosed in the concurrent Form 4, and it reveals the full mechanics of the exit — including the conversion of high-vote Class B shares into publicly tradable Class A shares. Despite the sales, Francisco Partners retains 52.6 million Class B shares (32.9% of the class), so this is a partial monetization rather than a complete exit. The distribution to limited partners creates potential future selling pressure as those partners may liquidate their newly received shares.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GDRX was trading at $3.48 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $1.77 to $5.81. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.